Australia's largest stock trading and investment forum Australia's #1 stock forum

ACR acrux limited

6.25%

1.7¢

FDA questions efficacy of testosterone and whether risks really do exist, page-9

First 9 Last

Share
Profile

Follow
Jasonsmsf

76 Posts.

12/09/14

19:16

Post #: 13968142
Share

Originally posted by Wazz101 ↑

Jason,

This is the $100 question! - the attached are the 3 submissions to the FDA from panel experts and the industry about the benefits and risks of taking T. If nothing else, read the exec summaries. If you own the shares (or plan to ), read the lot. The FDA are rolling the dice next Wednesday, although we wont see a result b4 November. The shares have been under a cloud since the FDA raised concerns in January.
Hope this helps!

Expand

thanks for the explanation, I hold 6000 shares and is likely to continue hold it. Don't think FDA will prohibit the use of it, all the medicines have side effect, people can choose use it or not. It is not drug.

ACR Price at posting: $1.55 Sentiment: None Disclosure: Unspecified
Upvote

0 Great analysis

Reply

Top Stories

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

First 9 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.7¢		Change 0.001(6.25%)		Mkt cap ! $6.931M

Open	High	Low	Value	Volume
1.6¢	1.7¢	1.6¢	$6.279K	376.7K

Buyers (Bids)

No.	Vol.	Price($)
3	741559	1.6¢

Sellers (Offers)

Price($)	Vol.	No.
1.7¢	193057	2

View Market Depth

No.	Vol.	Price($)
3	741559	0.016
6	1259314	0.015
3	420000	0.014
2	397000	0.013
1	80000	0.012

Price($)	Vol.	No.
0.017	193057	2
0.018	252359	2
0.019	677115	3
0.020	50000	1
0.021	203466	1

Last trade - 16.10pm 27/06/2025 (20 minute delay)

ACR (ASX) Chart

FDA questions efficacy of testosterone and whether risks really do exist, page-9

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Monash IVF shares cater 25% – Disaster or deep-value play?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

FDA questions efficacy of testosterone and whether risks really do exist, page-9

Top Stories

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Monash IVF shares cater 25% – Disaster or deep-value play?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News